These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11173620)

  • 21. Antibody response to Pseudomonas aeruginosa exoproducts in cancer patients.
    Crowe KE; Bass JA; Young VM; Straus DC
    J Clin Microbiol; 1982 Jan; 15(1):115-22. PubMed ID: 6821202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody responses to lipid A, core, and O sugars of the Pseudomonas aeruginosa lipopolysaccharide in chronically infected cystic fibrosis patients.
    Kronborg G; Fomsgaard A; Galanos C; Freudenberg MA; Høiby N
    J Clin Microbiol; 1992 Jul; 30(7):1848-55. PubMed ID: 1378455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reaction of antibody in sera from cystic fibrosis patients with non-toxic forms of Pseudomonas aeruginosa exotoxin A.
    Klinger KW; Shuster CW; Klinger J
    Eur J Clin Microbiol; 1985 Apr; 4(2):201-6. PubMed ID: 3924609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
    Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
    J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-LPS IgA and IgG Can Inhibit Serum Killing of Pseudomonas aeruginosa in Patients with Cystic Fibrosis.
    Pham A; Ledger EL; Coggon CF; Henderson IR; Reid DW; Bell SC; Smith DJ; Wells TJ
    Infect Immun; 2021 Nov; 89(12):e0041221. PubMed ID: 34460286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissociation of systemic and mucosal autoimmunity in cystic fibrosis.
    Theprungsirikul J; Skopelja-Gardner S; Meagher RE; Clancy JP; Zemanick ET; Ashare A; Rigby WFC
    J Cyst Fibros; 2020 Mar; 19(2):196-202. PubMed ID: 31262645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody to Pseudomonas aeruginosa mucoid exopolysaccharide and to sodium alginate in cystic fibrosis serum.
    Speert DP; Lawton D; Mutharia LM
    Pediatr Res; 1984 May; 18(5):431-3. PubMed ID: 6233529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum IgG antibody to outer membrane antigens of Pseudomonas cepacia and Pseudomonas aeruginosa in cystic fibrosis.
    Aronoff SC; Stern RC
    J Infect Dis; 1988 May; 157(5):934-40. PubMed ID: 2452219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative analysis of serum antibody responses to Pseudomonas aeruginosa exotoxin A by cystic fibrosis and intensive care unit patients.
    Cukor G; Blacklow NR; Nowak NA; Rich CM; Braverman LE; Fischer RA
    J Clin Microbiol; 1983 Sep; 18(3):457-62. PubMed ID: 6415090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential of preventing Pseudomonas aeruginosa lung infections in cystic fibrosis patients: experimental studies in animals.
    Johansen HK
    APMIS Suppl; 1996; 63():5-42. PubMed ID: 8944052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody response against Pseudomonas aeruginosa and its relationship with immune mediators in the upper and lower airways of cystic fibrosis patients.
    Mauch RM; Hentschel J; Aanaes K; Barucha A; Nolasco da Silva MT; Levy CE; Høiby N; Mainz JG
    Pediatr Pulmonol; 2020 Apr; 55(4):959-967. PubMed ID: 32022432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pseudomonas aeruginosa colonization causes PD-L1 overexpression on monocytes, impairing the adaptive immune response in patients with cystic fibrosis.
    Avendaño-Ortiz J; Llanos-González E; Toledano V; Del Campo R; Cubillos-Zapata C; Lozano-Rodríguez R; Ismail A; Prados C; Gómez-Campelo P; Aguirre LA; García-Río F; López-Collazo E
    J Cyst Fibros; 2019 Sep; 18(5):630-635. PubMed ID: 30442491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secretory IgA response against Pseudomonas aeruginosa in the upper airways and the link with chronic lung infection in cystic fibrosis.
    Mauch RM; Rossi CL; Aiello TB; Ribeiro JD; Ribeiro AF; Høiby N; Levy CE
    Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28645157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative studies on immunologically specific and non-specific absorption of Pseudomonas aeruginosa antibodies in serum from cystic fibrosis patients.
    Høiby N; Hertz JB
    Acta Pathol Microbiol Scand C; 1981 Jun; 89(3):185-92. PubMed ID: 6797245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anti-Pseudomonas aeruginosa antibodies, circulating immune complexes, and anticytoplasm antibodies of neutrophils in patients with cystic fibrosis with and without Pseudomonas aeruginosa colonization].
    Chiappini E; Taccetti G; Campana S; Turchini S; Marianelli L
    Pediatr Med Chir; 2001; 23(1):27-30. PubMed ID: 11486418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody response of rabbits and cystic fibrosis patients to an alginate-specific outer membrane protein of a mucoid strain of Pseudomonas aeruginosa.
    Rehm BH; Grabert E; Hein J; Winkler UK
    Microb Pathog; 1994 Jan; 16(1):43-51. PubMed ID: 8057826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Infections of the respiratory tract with Pseudomonas aeruginosa in cystic fibrosis].
    Winkler U; Wingender J; Jäger KE
    Klin Wochenschr; 1985 Jun; 63(11):490-8. PubMed ID: 3925219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-Avidity Autoantibodies against Bactericidal/Permeability-Increasing Protein Occur in Gram-Negative and Gram-Positive Bacteremia.
    Theprungsirikul J; Thaden JT; Wierzbicki RM; Burns AS; Skopelja-Gardner S; Fowler VG; Winthrop KL; Martin IW; Rigby WFC
    Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32747603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: Demonstration by radioimmunoassay.
    Klinger JD; Straus DC; Hilton CB; Bass JA
    J Infect Dis; 1978 Jul; 138(1):49-8. PubMed ID: 98596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pseudomonas-induced lung damage in cystic fibrosis correlates to bactericidal-permeability increasing protein (BPI)-autoantibodies.
    Carlsson M; Eriksson L; Erwander I; Wieslander J; Segelmark M
    Clin Exp Rheumatol; 2003; 21(6 Suppl 32):S95-100. PubMed ID: 14740434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.